The latest biotech news

News and Trends 20 Jul 2022

BigHat Biosciences raises $75M to design safer, more effective antibodies

A company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today (July 20) announced it has raised $75 million in funding. BigHat Biosciences’ series B funding round was led by Section 32 with participation from new investors Amgen Ventures, Bristol Myers Squibb, Quadrille Capital, Gaingels, GRIDS Capital and others. […]

July 20, 2022 - 4 minutesmins - By Liza Laws

News and Trends 20 Jul 2022

Upstaza gets nod from Europe for AADC deficiency treatment

PTC Therapeutics, Inc. says Upstaza (eladocagene exuparvovec) has been given marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency, and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older. “Today’s approval from the European […]

July 20, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

Iron protein can now be captured thanks to technology developed by NaviGo

An iron-storing protein can now be captured thanks to the successful development of a Precision Capturing affinity resin. Ferritin, an intracellular protein, is released into the bloodstream in small amounts where it acts as an iron carrier. Protein engineering company and developer of affinity ligands for custom chromatography solutions, NaviGo Proteins GmbH, announced today (July […]

July 20, 2022 - 3 minutesmins - By Liza Laws

News and Trends 20 Jul 2022

Plant-based nylon addressing urgent need for sustainable materials

Global brands need to take action by using sustainable materials with traceable and transparent supply chains, the CEO of a US biotech company says. Genomatica (Geno) alongside longtime collaborator Aquafil has just completed the first demonstration scale production runs for plant-based nylon-6. Christopher Schilling, Geno CEO says: “Now, more than ever, global brands are taking […]

July 20, 2022 - 3 minutesmins - By Liza Laws

News and Trends 20 Jul 2022

Business looks to grow life sciences sector in China

A Shanghai business says its top priority is to carry on contributing to the rapid growth of the life sciences sector in China. The ATLATL Center for Innovation & Research is a biopharma research-based open platform that builds laboratories and office spaces equipped with professional research and development (R&D) services, lab facilities and operations management. […]

July 20, 2022 - 3 minutesmins - By Liza Laws

researchers in lab; biotech collaboration

News and Trends 20 Jul 2022

LabShares Newton doubles space for biotech startups and launches pitch contest

LabShares Newton has opened 19,000 square feet of new incubator lab space for startup biotechs and expects to open another 6,000-foot lab in September. LabShares’ new space incorporates 12 private suites, 15 lab benches in the open lab, and a comprehensive set of shared resources and equipment. All private suites have already been committed to […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

ICL and PlantArcBio look to use RNAi to boost crop yields

ICL, a global specialty minerals company, and ag-biotech company PlantArcBio, Ltd., have announced the development of a novel bio-stimulant technology platform to improve crop yields while having a minimal impact on the environment. The platform uses RNAi (RNA interference) technology to maximize a plant’s natural yield increase mechanisms, without any genetic modification, and was the […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

WuXi Biologics to build new center in Singapore as part of $1.4B investment

WuXi Biologics, a global contract research, development and manufacturing organization (CRDMO), has announced a 10-year $1.4 billion investment plan. The plan aims to expand the company’s research, development, and large-scale drug substance and drug product (DS/DP) manufacturing capacity and capabilities in Singapore. The company will build a new site that will add 120,000L biomanufacturing capacity […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

Good news for Destiny Pharma’s nasal gel to combat life-threatening infections

Clinical stage biotech company, Destiny Pharma, announced today (July 19) a positive update from the U.S. Food and Drug Administration (FDA) on its XF-73 nasal gel phase 3 development plans. The FDA has clarified the phase 3 and U.S. registration pathway for the gel for the prevention of post-surgical staphylococcal infections, and this feedback enables […]

July 19, 2022 - 5 minutesmins - By Liza Laws

News and Trends 19 Jul 2022

Alpenglow Biosciences and CorePlus partner to bring 3D spatial biology to clinical R&D

Spatial biology company Alpenglow Biosciences is partnering with CorePlus, a high complexity CLIA-certified clinical and anatomic pathology laboratory, to digitize and analyze tissues in 3D to deliver novel spatial biology insights and accelerate drug development. As part of the partnership, CorePlus will invest in Alpenglow and receive access to Alpenglow’s 3Deep Imager, a hybrid open […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

eureKARE launches synthetic biology studio network

eureKARE, a company focused on financing and building next generation biotech companies in the fields of synthetic biology, has launched its first synthetic biology studio in Belgium. In conjunction with this, eureKARE has appointed Georges Rawadi as chief of biotech studio development. eureKARE said its thematic synthetic biology studio model is a novel, flexible approach […]

July 19, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis

Cells for Cells (C4C), a clinical-stage biotech allogeneic stem cell and stem-cells-derived therapeutics for high-impact chronic diseases, has announced a six-month follow-up of the clinical data from the first patient dosed with an exosome-produced therapy for osteoarthritis. The results were made public at an extracellular vesicles signature series during the ISCT annual meeting in San […]

July 19, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

BigHat Biosciences raises $75M to design safer, more effective antibodies

Upstaza gets nod from Europe for AADC deficiency treatment

Iron protein can now be captured thanks to technology developed by NaviGo

Plant-based nylon addressing urgent need for sustainable materials

Business looks to grow life sciences sector in China

LabShares Newton doubles space for biotech startups and launches pitch contest

ICL and PlantArcBio look to use RNAi to boost crop yields

WuXi Biologics to build new center in Singapore as part of $1.4B investment

Good news for Destiny Pharma’s nasal gel to combat life-threatening infections

Alpenglow Biosciences and CorePlus partner to bring 3D spatial biology to clinical R&D

eureKARE launches synthetic biology studio network

Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!